Want to see KMB full AI Analyst Report?
Operating Income by Segment
Shows profitability across different business segments, highlighting which areas are driving earnings and where there might be challenges or opportunities for improvement.Personal Care, Consumer Tissue and K‑C Professional delivered steady, positive operating income through Q3‑2024 while Corporate & Other absorbed a large mid‑2023 hit before narrowing to a much smaller loss by Q1‑2026. The abrupt zeros from Q4‑2024 point to a reporting/segment reclassification—likely linked to the Kenvue integration—rather than business collapse, but it materially reduces segment-level transparency. Management’s 6% productivity and margin‑expansion narrative fits the corporate improvement; watch Q2’s fire impact and potential H2 commodity exposure to see if pricing and productivity can actually offset these headwinds at the segment level.
Date | Corporate and Other | Personal Care | Consumer Tissue | K-C Professional |
|---|---|---|---|---|
Jun 30, 2026 | -$278.00M | $0.00 | $0.00 | $0.00 |
Mar 31, 2026 | -$115.00M | $0.00 | $0.00 | $0.00 |
Dec 31, 2025 | -$272.00M | $0.00 | $0.00 | $0.00 |
Sep 30, 2025 | -$233.00M | $0.00 | $0.00 | $0.00 |
Jun 30, 2025 | -$245.00M | $0.00 | $0.00 | $0.00 |
Mar 31, 2025 | -$207.00M | $0.00 | $0.00 | $0.00 |
Dec 31, 2024 | -$244.00M | $0.00 | $0.00 | $0.00 |
Sep 30, 2024 | -$318.00M | $482.00M | $265.00M | $161.00M |
Jun 30, 2024 | -$227.00M | $540.00M | $245.00M | $186.00M |
Mar 31, 2024 | -$132.00M | $545.00M | $290.00M | $188.00M |